Trial intelligence / Profile preview

Tuina vs Flurbiprofen for Chronic Nonspecific Low Back Pain

NCT04976790Unknown

Sponsor
Beijing University of Chinese Medicine
Start
Oct 2021
Primary completion
Feb 2022
Countries
1
01

Overview

Randomised, single-blind trial (2 arms), sponsored by Beijing University of Chinese Medicine. Primary endpoint: Numeric Rating Scale for Pain Intensity at 14 days. Status: unknown.

Beyond the preview

Go deeper on NCT04976790.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04976790.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call